At Anthony Nolan we have been saving and transforming lives for 50 years now. And we’ve made incredible progress over that time, introducing ground-breaking ways to treat blood cancer and blood disorders.
Research has been responsible for keeping us at the forefront of this cutting-edge science, and we know that research will be what keeps us pushing the boundaries and improving the future for the patients of today and the patients of tomorrow.
Our work focuses on three areas to have the most impact for our patients:
- Survival - To transform outcomes for every transplant patient
- Equity - To achieve greater equity of access, experience and outcomes
- Progress - To contribute to the development of new cell and gene therapies
We can only continue this lifesaving work thanks to your continued support and collaboration.
Learn more about our lifesaving research:
Our Research Strategy 2023-2028
We have produced an ambitious five-year research strategy to help us achieve our vision and deliver pioneering research that transforms patient survival, quality of life and equity.
Our latest research
Read all about our recent publications and updates on transplant related research breakthroughs, announcements and events.
Our research teams
From sequencing entire genes to improving post-transplant care - our experts use cutting edge technology to continually improve stem cell transplantation.
Our three world-class laboratory sites provide the perfect environment for scientific discovery and the development of new treatments.
The science behind our work
Have you ever wondered how we match the genes of our donors and patients? Or want to know what a ‘cell therapy’ is? Find the answers and more here.
The impact of our research
We have made many scientific discoveries and established key initiatives that have transformed how transplants are performed world-wide.
If you’re interested in collaborating with Anthony Nolan, or want the support of our Cell and Gene Services or commercial sequencing services, you can find out more in our Clinicians and Researchers section.